Item List

Highlights Q2 2024

Medical Device CMO Commercial Due Diligence
Bioprocessing Chromatography Market Forecast
Intraoperative Imaging Agent Clinical Development Strategy
Digital Health Provider Training Marketing Plan
Wireless Breast Lesion Localization Market Landscape
Drug Discovery Chromatography Strategic Market Analysis
Clinician Training Provider Growth Strategy
CRO Strategic Sales

Highlights Q1 2024

Advanced GI Market Strategic Planning
Life Science Tools Fundraising Support
Radiology Decision Support Tool Go-to-Market Strategy
Intraoperative Tumor Visualization Commercial Assessment
Biopharma Strategic Partnering Advisory
Clinical Trial Supplies and Logistics Landscape Analysis
Academic Medical Center 5-year Strategic Plan
Brain-Computer Interface Implant Go-to-Market Strategy
CRO Business Development Strategy
Stroke Aspiration Catheter Market Entry Planning
Enteral Feeding Technology Commercial Due Diligence

Cardiovascular Devices Review 2024

This report highlights company performance in select Cardiovascular (CV) device segments
• Revenue performance of key public companies, as well as M&A and investments: Abbott, Boston Scientific, Edwards Lifesciences, J&J, and Medtronic
• Overview of VC investments, M&A and IPOs for select segments of interest: Atrial fibrillation, mechanical circulatory support, cardiac monitoring, cardiac rhythm management (CRM), and transcatheter valves